Rosner Elimelech Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$2.16M

Insider Activity of Rosner Elimelech

According to the SEC Form 4 filings, Rosner Elimelech, being in a position of

  1. EVP, CHIEF TECHNOLOGY OFFICER at HealthEquity, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10959 shares for $1.05M,
    over all time since 2023-06-12, has bought 0 shares, and sold 111295 shares for $11.19M.

Biography of Rosner Elimelech

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,046,0901100

Comparison of Insiders on Amount of Buys and Sells

2025-12-18SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
10,959
0.0127%
$95.45$1.05M-7.5%
2025-06-09SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
13,000
0.0151%
$111.37$1.45M-18.08%
2025-06-06SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
58,000
0.0677%
$112.56$6.53M-18.36%
2024-12-12SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
2,869
0.0034%
$97.12$278,635+1.23%
2024-09-06SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
12,296
0.0142%
$77.02$947,090+25.97%
2023-12-11SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
2,017
0.0023%
$70.09$141,364+12.55%
2023-09-22SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
1,998
0.0023%
$71.92$143,704+6.46%
2023-06-12SaleHealthEquity, Inc.
HQY
EVP, CHIEF TECHNOLOGY OFFICER
10,156
0.012%
$64.29$652,925+13.06%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.